Nuo Therapeutics, Inc | 2013 | FY | 3


Non-cash Investing and Financing transactions for years ended December 31 include:
 
 
 
 
2013
 
2012
Conversion of convertible debt to common stock
 
$
523,927
 
 
$
924,904
 
Preferred dividends paid by issuance of stock
 
 
 
 
 
82,500
 
Business combination:
 
 
  
 
 
 
  
 
Issuance of Series E liability
 
 
 
 
 
18,955,742
 
Issuance of contingent consideration
 
 
 
 
 
11,109,020
 
Issuance of replacement warrants
 
 
 
 
 
1,883,751
 
Common stock issued in satisfaction of subscription receivable
 
 
 
 
 
2,790,107
 
Effect of cancellation of escrowed shares
 
 
 
 
 
195,132
 
Obligation to issue shares for professional services
 
 
 
 
 
30,000
 
Effect of modification of convertible debt
 
 
151,032
 
 
 
 
Common Stock issued for committed equity financing facility
 
 
204,015
 
 
 
 
Warrants issued for term loan modification
 
 
151,758
 
 
 
 
Warrants issued for term loan
 
 
568,324
 
 
 
 
Common stock and warrants issued for release of security interest in patents
 
 
325,693
 
 
 
 
Warrants issued in connection with convertible debt
 
 
1,353,842
 
 
 
 
Derivative liability for embedded conversion option
 
 
965,484
 
 
 
 
Common stock issued for professional services
 
 
17,850
 
 
 
 
Common stock issued for settlement of contingency
 
 
39,150
 
 
 
 

us-gaap:DetailsOfNonmonetaryTransactionsTableTextBlock